Patients affected by new coronavirus infectious disease (COVID) were mostly hospitalized in ICU. This infection seems to cause widespread organ injury (i.e acute renal injury, neurological disorders, pulmonary embolism,…). It is therefore necessary to provide a framework for the follow up of patients. Moreover SARS-CoV-2 infection consequences remain unknow at this time. Study hypothesis is that COVID alters determining factors (physical or psychological) of quality of life after ICU hospitalisation. The aim of the study is to assess quality of life 3 months after ICU hospitalization. Secondary purposes of the study are 1) assessment of quality of life 6 months and the evolution between the third and the sixth months after ICU hospitalization 2) description patients care after 3 and 6 months ICU left and their clinical status 3) convening and providing a "platform" within several physicians (neurologist, biologist, pneumologist…) will be able to follow up patients and perform complementary investigations according to patients injuries.
Study Type
OBSERVATIONAL
Enrollment
112
quality of live assessment 3 moth and 6 moth after ointensive care hospitalisation using SF36.
Hôpitaux Universitaires de Strasbourg (Nouvel Hôpital Civil)
Strasbourg, France
assess quality of life after severe COVID infection
assess different dimensions of quality of life: physical and mentaland social dimensions
Time frame: measured at 3 months after ICU left.
Quality of life and Clinical status
Clinical status of patients and assessment of quality of life. collects crucial elements of care based on doctors' prescriptions
Time frame: measured at 3 and 6 months after ICU left.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.